• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四种人肺癌细胞系的体外单剂量和分次照射

Single-dose and fractionated irradiation of four human lung cancer cell lines in vitro.

作者信息

Brodin O, Lennartsson L, Nilsson S

机构信息

Department of Oncology, Akademiska Sjukhuset, University of Uppsala, Sweden.

出版信息

Acta Oncol. 1991;30(8):967-74. doi: 10.3109/02841869109088251.

DOI:10.3109/02841869109088251
PMID:1663776
Abstract

Four established human lung cancer cell lines were exposed to single-dose irradiation. The survival curves of 2 small cell lung carcinomas (SCLC) were characterized by a limited capacity for repair with small and moderate shoulders with extrapolation numbers (n) of 1.05 and 1.60 respectively. Two non-small cell lung carcinoma (NSCLC) cell lines, one squamous cell (SQCLC) and one large cell (LCLC) had large shoulders with n-values of 73 and 15 respectively. The radiosensitivity when measured as D0 did not, however, differ as much from cell line to cell line, with values from 1.22 to 1.65. The surviving fraction after 2 Gy (SF2) was 0.24 and 0.42 respectively in the SCLC cell lines and 0.90 and 0.88 respectively in the NSCLC cell lines. Fractionated irradiation delivered according to 3 different schedules was also investigated. All the schedules delivered a total dose of 10 Gy in 5 days and were applied in 1, 2, and 5 Gy dose fractions respectively. Survival followed the pattern found after single-dose irradiation; it was lowest in the SCLC cell line with the lowest SF and highest in the two NSCLC cell lines. In the SCLC cell lines all schedules were approximately equally efficient. In the LCLC and in the SQCLC cell lines, the 5 Gy schedule killed more cells than the 1 and 2 Gy schedules. The results indicate that the size of the shoulder of the survival curve is essential when choosing the most tumoricidal fractionation schedule.

摘要

四种已建立的人肺癌细胞系接受了单剂量照射。2种小细胞肺癌(SCLC)的存活曲线特点是修复能力有限,有小的和中等大小的肩区,外推数(n)分别为1.05和1.60。2种非小细胞肺癌(NSCLC)细胞系,一种是鳞状细胞癌(SQCLC),一种是大细胞癌(LCLC),有大的肩区,n值分别为73和15。然而,以D0衡量的放射敏感性在各细胞系之间差异不大,数值在1.22至1.65之间。SCLC细胞系中2 Gy照射后的存活分数(SF2)分别为0.24和0.42,NSCLC细胞系中分别为0.90和0.88。还研究了按照3种不同方案进行的分次照射。所有方案均在5天内给予总剂量10 Gy,分别以1、2和5 Gy的剂量分次给予。存活情况遵循单剂量照射后的模式;在SF最低的SCLC细胞系中最低,在2种NSCLC细胞系中最高。在SCLC细胞系中,所有方案的效率大致相同。在LCLC和SQCLC细胞系中,5 Gy方案比1 Gy和2 Gy方案杀死的细胞更多。结果表明,在选择最具肿瘤杀伤性的分次照射方案时,存活曲线肩区的大小至关重要。

相似文献

1
Single-dose and fractionated irradiation of four human lung cancer cell lines in vitro.四种人肺癌细胞系的体外单剂量和分次照射
Acta Oncol. 1991;30(8):967-74. doi: 10.3109/02841869109088251.
2
Radiation sensitivity of human lung cancer cell lines.人肺癌细胞系的辐射敏感性。
Eur J Cancer Clin Oncol. 1989 Mar;25(3):527-34. doi: 10.1016/0277-5379(89)90266-6.
3
Fractionated irradiation of five human lung cancer cell lines and prediction of survival according to a radiobiology model.分阶段照射五种人肺癌细胞系,并根据放射生物学模型预测生存情况。
Anticancer Res. 2011 Apr;31(4):1125-30.
4
Cellular radiosensitivity of small-cell lung cancer cell lines.小细胞肺癌细胞系的细胞放射敏感性。
Int J Radiat Oncol Biol Phys. 1997 Apr 1;38(1):191-6. doi: 10.1016/s0360-3016(97)00245-9.
5
Inhibiting the aurora B kinase potently suppresses repopulation during fractionated irradiation of human lung cancer cell lines.抑制极光 B 激酶能有效抑制人肺癌细胞系在分割照射中的再增殖。
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):492-9. doi: 10.1016/j.ijrobp.2011.12.021. Epub 2012 Feb 28.
6
Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation.从超分割放疗转向“常规”分割胸部放疗:一家机构使用同步放化疗治疗局限期小细胞肺癌的10年经验。
Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):709-16. doi: 10.1016/s0360-3016(03)00635-7.
7
Radiation responsiveness of human lung cancer cell lines measured with a short term semiautomatic assay.用人肺癌细胞系的短期半自动检测法测量辐射反应性。
Anticancer Res. 2001 Nov-Dec;21(6A):3925-8.
8
Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.放射免疫疗法与体外及体内人肾细胞癌异种移植瘤外照射放疗的放射生物学研究。
Cancer. 1997 Dec 15;80(12 Suppl):2519-28. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2519::aid-cncr26>3.3.co;2-t.
9
Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system.人类肿瘤细胞系分次照射敏感性的异质性:三维模型系统研究
Int J Radiat Oncol Biol Phys. 1995 May 15;32(2):395-408. doi: 10.1016/0360-3016(95)00528-7.
10
[Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].[IV期非小细胞肺癌患者放疗后的生存状况——附287例报告]
Ai Zheng. 2006 Nov;25(11):1419-22.

引用本文的文献

1
EPHA2 Interacts with DNA-PK in Cell Nucleus and Controls Ionizing Radiation Responses in Non-Small Cell Lung Cancer Cells.EPHA2在细胞核中与DNA-PK相互作用并调控非小细胞肺癌细胞的电离辐射反应。
Cancers (Basel). 2021 Feb 28;13(5):1010. doi: 10.3390/cancers13051010.
2
Kinetic modeling of tumor regression incorporating the concept of cancer stem-like cells for patients with locally advanced lung cancer.纳入癌症干细胞样细胞概念的局部晚期肺癌患者肿瘤消退动力学模型
Theor Biol Med Model. 2018 Dec 27;15(1):23. doi: 10.1186/s12976-018-0096-7.
3
Inhibition of Ephrin B3-mediated survival signaling contributes to increased cell death response of non-small cell lung carcinoma cells after combined treatment with ionizing radiation and PKC 412.
抑制 Ephrin B3 介导的生存信号有助于非小细胞肺癌细胞在接受电离辐射和 PKC 412 联合治疗后增加细胞死亡反应。
Cell Death Dis. 2013 Jan 10;4(1):e454. doi: 10.1038/cddis.2012.188.
4
Effects of redox modulation by inhibition of thioredoxin reductase on radiosensitivity and gene expression.硫氧还蛋白还原酶抑制的氧化还原调节对放射敏感性和基因表达的影响。
J Cell Mol Med. 2012 Jul;16(7):1593-605. doi: 10.1111/j.1582-4934.2011.01469.x.
5
Datamining approaches for modeling tumor control probability.肿瘤控制概率建模的数据挖掘方法。
Acta Oncol. 2010 Nov;49(8):1363-73. doi: 10.3109/02841861003649224. Epub 2010 Mar 2.